Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07161960Not ApplicableRecruiting

Early Versus Delayed Cholecystectomy After Percutaneous Cholecystostomy in Moderate and Severe Cholecystitis (ESCAPE)

Role: collaborator

NCT06169566Not ApplicableUnknown

The Synbiotics Effects in Polycystic Ovary Syndrome: A Randomized Controlled Trial

Role: lead

NCT03931850Not ApplicableUnknown

Does Neurostimulation Improve Efficacy for Ultrasound-Guided Transperineal Pudendal Nerve Block In Children

Role: collaborator

NCT01580865Not ApplicableCompleted

Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis

Role: collaborator

NCT03329222Not ApplicableTerminated

An Infant Formula Trial on Dietary Management of Infantile Colic

Role: collaborator

All 5 trials loaded